Injectable cement market seen reaching $2.13 billion by 2030

The injectable cement market is forecast to grow from $1.55 billion in 2025 to $1.66 billion in 2026, with demand rising across orthopedic care and sports injury treatment. North America held the largest share in 2025, while Asia-Pacific is expected to be the fastest-growing region through 2030.

Why it matters: - Injectable cement is becoming more important as orthopedic care shifts toward minimally invasive procedures and faster recovery. - Growth is tied to aging populations, more bone injuries and broader use of image-guided treatment. - The market’s expansion signals more demand for bone stabilization products in hospitals, outpatient centers and clinics.

What happened: - The injectable cement market was valued at $1.55 billion in 2025 and is projected to reach $1.66 billion in 2026. - The market is forecast to climb to $2.13 billion by 2030. - The projected growth rates are 6.7% from 2025 to 2026 and 6.4% from 2026 to 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample report is available here. - The full report is available here.

The details: - Injectable cement is a type of bone cement used to stabilize fractures, support implants and fill bone defects. - The material is injected into targeted areas, often with imaging guidance, to improve placement accuracy and reduce invasiveness. - Immediate structural support is one of the product’s main clinical uses. - Historical growth has been supported by more bone fractures, continued use of traditional orthopedic fixation techniques, a growing elderly population, more hospital-based orthopedic treatments and widespread use of PMMA-based bone cements. - Future growth is expected to come from improved injectable cement formulations, higher demand for minimally invasive surgery, more orthopedic trauma cases, expansion of outpatient and clinic-based procedures, and stronger interest in biocompatible and bioactive materials. - Key trends include broader adoption of minimally invasive techniques, more use in fracture stabilization, preference for image-guided injections, advances in bioactive and composite cements, and a focus on better recovery times and outcomes.

Between the lines: - Sports injuries are adding another layer of demand as more athletes and active consumers seek fracture stabilization and bone-healing support. - Australian Institute of Health and Welfare data showed cycling accounted for 12% of sports-related hospitalizations in 2023-24, or about 7,500 cases. - Australian rules football made up 8.7% of those hospitalizations, or about 5,400 cases. - Soccer accounted for 8.6%, or roughly 5,300 cases. - The regional split suggests mature demand in North America and faster adoption potential in Asia-Pacific. - The market report’s focus on TAM analysis, company scoring, hotspots and forecasting dashboards points to a sector where investors and suppliers are looking for specific growth pockets rather than broad-based expansion.

What's next: - Product development is likely to center on bioactive and composite cement materials. - More procedures may move into outpatient and clinic settings as minimally invasive orthopedic techniques expand. - Demand should continue rising as sports injuries, trauma cases and aging-related bone conditions increase. - The market’s strongest near-term opportunity appears to be in regions and product lines that support faster recovery and image-guided procedures.

The bottom line: - Injectable cement is moving from a niche orthopedic tool to a broader growth market, with steady gains expected through 2030 as surgery techniques, patient demographics and injury rates keep pushing demand higher.